House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Neonatology

Specialist neonatal respiratory care for babies born preterm

NICE · 2019 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

NICE specialist neonatal respiratory guidance covers support from early stabilisation through neonatal-unit care and discharge. It combines ventilation choices, selective adjunct medicines and physiological targets with pain assessment and practical family preparation. The recommendations apply to preterm babies and must be interpreted within neonatal specialist care.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Prefer appropriate noninvasive support and timely surfactant

  • When stabilising a preterm newborn who needs respiratory support before neonatal-unit admission, use CPAP rather than invasive ventilation when clinically appropriate. [1]
  • Give surfactant when invasive ventilation is needed for early stabilisation. If surfactant is needed without an invasive-ventilation requirement, use a minimally invasive technique; when this is not feasible, intubate for administration and extubate early afterwards. [1]
  • Use nasal cannula or incubator oxygen for supplemental oxygen, humidifying at higher flows such as at least 2 litres/minute. For noninvasive ventilation, consider nasal CPAP or nasal high-flow therapy. [1]

Choose ventilatory techniques and avoid routine nitric oxide

  • For invasive support, use volume-targeted ventilation combined with synchronisation as the primary mode. If ineffective, consider high-frequency oscillatory ventilation. [1]
  • If volume-targeted and high-frequency oscillatory ventilation are unavailable or unsuitable, consider synchronised intermittent mandatory ventilation. Do not use synchronised pressure-limited modes such as assist control, synchronised intermittent positive pressure ventilation, patient-triggered ventilation, pressure support ventilation or synchronised time-cycled pressure-limited ventilation. [1]
  • Do not routinely use inhaled nitric oxide for respiratory distress syndrome in preterm babies. Other indications, such as pulmonary hypoplasia or pulmonary hypertension, are separate considerations. [1]

Use corticosteroids, caffeine and ductal treatment selectively

  • Consider dexamethasone for a preterm infant aged at least 8 days who still needs invasive ventilation for respiratory disease, taking BPD risk into account and discussing benefits and harms with the family. [1]
  • Before age 8 days, dexamethasone increases gastrointestinal-perforation risk. Do not combine dexamethasone with NSAIDs, and monitor blood pressure during treatment because of hypertension risk. [1]
  • Use caffeine citrate routinely in infants born at or before 30 weeks, beginning as early as possible and ideally before day 3. Consider stopping at 33–35 weeks corrected gestational age if clinically stable. [1]
  • Consider caffeine citrate for any preterm infant with apnoea. The stated loading dose is 20 mg/kg, with 5 mg/kg daily maintenance starting 24 hours later and increasing up to 20 mg/kg daily if apnoea persists. [1]
  • Caffeine citrate maintenance above 20 mg/kg daily should only be considered when efficacy is inadequate while maintaining a safe plasma concentration. Use the local laboratory’s reference range when interpreting measurements. [1]
  • Do not treat a patent ductus arteriosus solely because it is present; treatment is indicated when it causes a significant clinical problem, such as difficulty weaning ventilation. [1]

Monitor gas exchange and perfusion

  • Use continuous pulse oximetry, with arterial sampling when indicated. After initial stabilisation, aim for saturation of 91–95%, recognising possible inaccuracy of borderline readings and reported overestimation in darker skin. [1]
  • For invasive ventilation, the stated carbon dioxide target is 4.5–8.5 kPa on days 1–3 and 4.5–10 kPa from day 4. If carbon dioxide is low, reduce minute ventilation promptly and repeat the measurement within an hour. [1]
  • Do not treat hypotension using a blood-pressure threshold alone. Assess tissue perfusion and other clinical factors, with improving perfusion as the treatment goal. [1]

Address pain and include parents as care partners

  • Do not routinely use morphine merely because an infant needs respiratory support. Consider it for assessed pain and reassess regularly so it can stop as soon as possible. [1]
  • Consider premedication for elective, nonurgent intubation. The listed options are an opioid analgesic combined with a neuromuscular blocker, or propofol alone; this recommendation does not describe emergency intubation. [1]
  • Recognise parents and carers as partners, involve them in daily care and decisions, and provide time for questions and support to build confidence. Offer professional psychological support where needed. [1]
  • Explain benefits of touch and skin-to-skin contact, and non-nutritive sucking while awake. Provide current written information that is consistent across clinicians and adapted to the family’s needs. [1]

Prepare caregivers and community support before going home

  • Consider early referral to, and regular contact with, community and continuing healthcare teams and consider a designated discharge coordinator to explain follow-up, home care, equipment and travel. Include parents in discharge decisions. [1]
  • Assess safe equipment use with a formal competency tool, discuss home modifications early, and teach responses to emergencies, including resuscitation and equipment failure. Offer opportunities for overnight caregiving before discharge. [1]

Limitations and use

  • The summary does not give a complete ventilator-setting protocol, dexamethasone regimen or emergency intubation sequence.
  • Drug formulations, plasma monitoring and off-label use need the local prescribing context; source regulatory notes are UK-specific and dated.
  • BPD associations with surfactant or ductal treatment reflect illness severity and are not reasons to withhold clinically appropriate treatment.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Specialist neonatal respiratory care for babies born preterm

    Selected recommendation material consulted

Clinical guideline

Publication details

Issuing organisation
NICE
First published
3 April 2019
Resource type
Clinical guideline · House clinical summary
Source setting
United Kingdom

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Prefer appropriate noninvasive support and timely surfactant
  • Choose ventilatory techniques and avoid routine nitric oxide
  • Use corticosteroids, caffeine and ductal treatment selectively
  • Monitor gas exchange and perfusion
  • Address pain and include parents as care partners
  • Prepare caregivers and community support before going home
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House